Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat

Bahra, 2001, Brainstem activation specific to migraine headache, Lancet, 357, 1016, 10.1016/S0140-6736(00)04250-1 Edvinsson, 2004, Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache, Cephalalgia, 24, 611, 10.1111/j.1468-2982.2003.00719.x Edvinsson, 2008, CGRP-receptor antagonism in migraine treatment, Lancet, 372, 2089, 10.1016/S0140-6736(08)61710-9 Edvinsson, 2008, CGRP blockers in migraine therapy: where do they act?, Br. J. Pharmacol., 155, 967, 10.1038/bjp.2008.346 Edvinsson, 2005, Neurobiology in primary headaches, Brain Res. Rev., 48, 438, 10.1016/j.brainresrev.2004.09.007 Eftekhari, 2010, Differential distribution of calcitonin gene-related peptide (CGRP) and CGRP receptor components (CLR and RAMP1) in the human trigeminal ganglion, Neuroscience, 169, 683, 10.1016/j.neuroscience.2010.05.016 Goadsby, 2002, Migraine—current understanding and treatment, N Engl J. Med., 346, 257, 10.1056/NEJMra010917 Gregg, 1999, Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex, J. Neurocytol., 28, 431, 10.1023/A:1007032119792 Ho, 2008, Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial, Lancet, 372, 2115, 10.1016/S0140-6736(08)61626-8 Ho, 2008, Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine, Neurology, 70, 1304, 10.1212/01.WNL.0000286940.29755.61 Ho, 2010, CGRP and its receptor provide new insights into migraine pathophysiology, Nat. Rev. Neurol., 6, 573, 10.1038/nrneurol.2010.127 Kawai, 1985, Topographic localization of calcitonin gene-related peptide in the rat brain: an immunohistochemical analysis, Neuroscience, 15, 747, 10.1016/0306-4522(85)90076-4 Lee, 1985, Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis, Brain Res., 330, 194, 10.1016/0006-8993(85)90027-7 May, 1999, The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation, J. Cereb. Blood Flow Metab., 19, 115, 10.1097/00004647-199902000-00001 McLatchie, 1998, RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor, Nature, 393, 333, 10.1038/30666 Morara, 1989, CGRP expression in the rat olivocerebellar system during postnatal development, Brain Res., 504, 315, 10.1016/0006-8993(89)91376-0 Morara, 2000, Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: an autoradiographic and immunohistochemical analysis, Neuroscience, 100, 381, 10.1016/S0306-4522(00)00276-1 Morara, 2001, Ultrastructural analysis of climbing fiber-Purkinje cell synaptogenesis in the rat cerebellum, Neuroscience, 108, 655, 10.1016/S0306-4522(01)00433-X Morara, 1998, Monoclonal antibodies reveal expression of the CGRP receptor in Purkinje cells, interneurons and astrocytes of rat cerebellar cortex, NeuroReport, 9, 3755, 10.1097/00001756-199811160-00034 Olesen, 2004, Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine, N Engl J. Med., 350, 1104, 10.1056/NEJMoa030505 Oliver, 2001, Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat, Eur. J. Neurosci., 14, 618, 10.1046/j.0953-816x.2001.01688.x Ueda, 2001, Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain, Brain Res. Mol. Brain Res., 93, 36, 10.1016/S0169-328X(01)00179-6 Vincent, 2007, The cerebellum and migraine, Headache, 47, 820, 10.1111/j.1526-4610.2006.00715.x Weiller, 1995, Brain stem activation in spontaneous human migraine attacks, Nat. Med., 1, 658, 10.1038/nm0795-658